The antifibrotic role of natural killer cells in liver fibrosis.


Journal

Experimental biology and medicine (Maywood, N.J.)
ISSN: 1535-3699
Titre abrégé: Exp Biol Med (Maywood)
Pays: England
ID NLM: 100973463

Informations de publication

Date de publication:
07 2022
Historique:
pubmed: 28 4 2022
medline: 13 8 2022
entrez: 27 4 2022
Statut: ppublish

Résumé

Liver fibrosis is the common pathological change of chronic liver diseases characterized by increased deposition of extracellular matrix and reduced matrix degradation. In response to liver injury caused by a variety of pathogenic agents, such as virus and alcohol, hepatic stellate cells (HSCs) are differentiated into myofibroblast-like cells and produce excessive collagens, thus resulting in fibrogenesis. Natural killer (NK) cells are the essential innate immune cells in the liver and generally control fibrosis by killing activated HSCs. This review briefly describes the fibrogenesis process and the phenotypic features of hepatic NK cells. Besides, it focuses on the antifibrotic mechanisms of NK cells and explores the potential of activating NK cells as a therapeutic strategy for the disease.

Identifiants

pubmed: 35475367
doi: 10.1177/15353702221092672
pmc: PMC9379607
doi:

Types de publication

Journal Article Review Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1235-1243

Références

J Hepatol. 2013 Oct;59(4):738-45
pubmed: 23747755
Front Immunol. 2019 Sep 11;10:2180
pubmed: 31572388
Cell Signal. 2017 May;33:79-85
pubmed: 28188823
Medicine (Baltimore). 2016 May;95(19):e3678
pubmed: 27175704
PLoS One. 2012;7(11):e49135
pubmed: 23133672
Front Immunol. 2017 Jan 11;7:692
pubmed: 28123389
Hepatology. 2006 Dec;44(6):1441-51
pubmed: 17133483
J Exp Med. 2007 Mar 19;204(3):667-80
pubmed: 17353365
Biomed Pharmacother. 2018 Oct;106:1332-1338
pubmed: 30119204
Hepatology. 2014 Mar;59(3):898-910
pubmed: 23813842
Lab Invest. 2012 Jul;92(7):967-77
pubmed: 22449797
PLoS One. 2015 Aug 20;10(8):e0135874
pubmed: 26291078
Acta Pharmacol Sin. 2016 Feb;37(2):204-16
pubmed: 26592510
Gastroenterology. 2010 May;138(5):1885-97
pubmed: 20334827
Hepatology. 2014 Sep;60(3):1044-53
pubmed: 24668648
Gastroenterology. 2006 Feb;130(2):435-52
pubmed: 16472598
Am J Physiol Gastrointest Liver Physiol. 2007 Oct;293(4):G809-16
pubmed: 17673545
Hepatology. 2007 Nov;46(5):1509-18
pubmed: 17705260
Front Immunol. 2019 Jun 04;10:1255
pubmed: 31214196
Hum Cell. 2020 Jul;33(3):582-589
pubmed: 32449114
Hepatology. 1995 Jun;21(6):1585-93
pubmed: 7768503
Hepatology. 2011 Jan;53(1):219-29
pubmed: 21140473
PLoS One. 2014 Apr 23;9(4):e95614
pubmed: 24759660
Hepatology. 2009 May;49(5):1683-94
pubmed: 19205035
Immunol Lett. 2021 Apr;232:9-19
pubmed: 33515618
PLoS Negl Trop Dis. 2012 Jan;6(1):e1456
pubmed: 22235358
Hepatology. 2012 Sep;56(3):841-9
pubmed: 22431186
Crit Rev Immunol. 2011;31(1):43-52
pubmed: 21395510
J Hepatol. 2019 Sep;71(3):573-585
pubmed: 31071368
Gastroenterology. 2018 Aug;155(2):282-302.e8
pubmed: 29906416
Hepatology. 2004 May;39(5):1321-31
pubmed: 15122761
Hepatology. 2014 Dec;60(6):1879-90
pubmed: 25066464
Semin Immunol. 2002 Dec;14(6):453-60
pubmed: 12457618
Front Pharmacol. 2018 Jul 16;9:762
pubmed: 30061833
Hepatology. 2007 Sep;46(3):706-15
pubmed: 17626270
Sci Rep. 2017 Dec;7(1):88
pubmed: 28273905
J Exp Med. 2009 Aug 3;206(8):1727-37
pubmed: 19635861
Cell Mol Gastroenterol Hepatol. 2015 Nov;1(6):578-588
pubmed: 26682281
PLoS One. 2015 May 29;10(5):e0127946
pubmed: 26024318
Lab Invest. 2015 Feb;95(2):223-36
pubmed: 25531568
Semin Liver Dis. 2010 Aug;30(3):226-31
pubmed: 20665375
Int J Mol Sci. 2019 Oct 13;20(20):
pubmed: 31614928
Hepatol Commun. 2018 Feb 14;2(3):285-298
pubmed: 29507903
Front Med (Lausanne). 2015 Oct 05;2:72
pubmed: 26501061
Cytokine Growth Factor Rev. 2011 Feb;22(1):35-43
pubmed: 21334249
Annu Rev Immunol. 2005;23:225-74
pubmed: 15771571
Mol Aspects Med. 2019 Feb;65:37-55
pubmed: 30213667
Front Immunol. 2019 Apr 30;10:946
pubmed: 31114585
PLoS One. 2013 Dec 10;8(12):e82571
pubmed: 24340043
Alcohol Clin Exp Res. 2006 Sep;30(9):1615-23
pubmed: 16930225
Scand J Immunol. 2019 Aug;90(2):e12775
pubmed: 31069827
Dig Liver Dis. 2016 May;48(5):528-535
pubmed: 26860239
Expert Rev Gastroenterol Hepatol. 2007 Oct;1(1):173-80
pubmed: 19072444
Gut. 2006 Jun;55(6):869-77
pubmed: 16322112
Front Med. 2018 Jun;12(3):269-279
pubmed: 29675689
Oncogene. 2013 Apr 11;32(15):1971-7
pubmed: 22751116
J Immunotoxicol. 2012 Jul-Sep;9(3):267-74
pubmed: 22524686
Gastroenterology. 2010 Apr;138(4):1536-45
pubmed: 20080094
J Autoimmun. 2010 Dec;35(4):424-35
pubmed: 20932719
Mol Med. 2020 Sep 1;26(1):81
pubmed: 32873229
PLoS One. 2014 Feb 10;9(2):e86927
pubmed: 24520324
Front Cell Infect Microbiol. 2020 Nov 19;10:598987
pubmed: 33330140
Gastroenterology. 2018 Nov;155(5):1366-1371.e3
pubmed: 30031767
Hepatology. 2010 Jan;51(1):92-102
pubmed: 19998387
J Int AIDS Soc. 2019 Sep;22(9):e25375
pubmed: 31536177
Hepatology. 2016 Jul;64(1):209-23
pubmed: 26710118
J Leukoc Biol. 2002 Oct;72(4):668-76
pubmed: 12377935
Hepatology. 2018 Feb;67(2):736-749
pubmed: 28902427
Sci Rep. 2017 Mar 14;7:44544
pubmed: 28291251
Hepatology. 2006 Mar;43(3):435-43
pubmed: 16496318
Hepatology. 2016 Mar;63(3):799-812
pubmed: 26662852
Gastroenterology. 2009 Sep;137(3):1151-60, 1160.e1-7
pubmed: 19470388
J Hepatol. 2017 Oct;67(4):770-779
pubmed: 28596109
Hepatology. 2012 Oct;56(4):1201-13
pubmed: 22532190
J Leukoc Biol. 2019 Apr;105(4):695-704
pubmed: 30748035
Am J Physiol Gastrointest Liver Physiol. 2013 Dec;305(12):G891-9
pubmed: 24136786
Front Immunol. 2021 Feb 18;12:640869
pubmed: 33679803
J Hepatol. 2014 Dec;61(6):1376-84
pubmed: 25064435
Proc Natl Acad Sci U S A. 2014 Aug 12;111(32):E3297-305
pubmed: 25074909
Gastroenterology. 2008 Jan;134(1):248-58
pubmed: 18166357
Pathog Immun. 2018;3(1):2-18
pubmed: 29541698
Blood. 2001 May 15;97(10):3146-51
pubmed: 11342442
Front Immunol. 2020 Feb 25;11:129
pubmed: 32161581
Annu Rev Pathol. 2017 Jan 24;12:153-186
pubmed: 27959632
Alcohol Clin Exp Res. 1996 Aug;20(5):900-7
pubmed: 8865966
J Hepatol. 2019 Aug;71(2):252-264
pubmed: 30905683
Gut. 2012 Jun;61(6):885-93
pubmed: 22198715
Hepatology. 2021 Oct;74(4):2170-2185
pubmed: 33932306
Gut. 2011 Jan;60(1):90-8
pubmed: 20660699
J Immunol. 2010 Jan 1;184(1):466-75
pubmed: 19949088
Clin Immunol. 2009 Jan;130(1):16-26
pubmed: 18823822
PLoS One. 2012;7(7):e38846
pubmed: 22792160
Front Med (Lausanne). 2021 Apr 01;8:604894
pubmed: 33869241
Hepatology. 1997 May;25(5):1096-100
pubmed: 9141423
Hepatology. 2015 Mar;61(3):1066-79
pubmed: 25066777
Eur J Clin Invest. 2016 Oct;46(10):864-72
pubmed: 27555302
J Hepatol. 2006 Jul;45(1):60-71
pubmed: 16515819
Cell Death Differ. 2008 Feb;15(2):251-62
pubmed: 17975553
Dig Dis Sci. 1991 Mar;36(3):299-302
pubmed: 1995265
Liver Int. 2020 Mar;40(3):598-608
pubmed: 31758647
Hepatology. 1992 Sep;16(3):776-84
pubmed: 1505921
Immunol Cell Biol. 2011 Feb;89(2):216-24
pubmed: 20567250

Auteurs

Yuan Wei (Y)

Department of Hepatology, The First Affiliated Hospital of Hunan University of Traditional Chinese Medicine, Changsha 410000, China.

Wang Bingyu (W)

Department of Gastroenterology, Heilongjiang Academy of Traditional Chinese Medicine, Harbin 150001, China.

Yang Lei (Y)

Department of Gastroenterology, Heilongjiang Academy of Traditional Chinese Medicine, Harbin 150001, China.

Yuan Xingxing (Y)

Department of Gastroenterology, Heilongjiang Academy of Traditional Chinese Medicine, Harbin 150001, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH